mHTT-IN-2 is a potent inhibitor of mutant huntingtin protein (mHTT) (EC50 = 0.066 μM); it reduces canonical splicing of HTT RNA exons 49–50 and acts as a splicing modulator of the huntingtin (HTT) gene; it exhibits in vitro and in vivo inhibitory activity in human HD stem cells and the mouse BACHD model; it can be used in the study of branaplam-associated peripheral neuropathy.